Clinical Research Directory
Browse clinical research sites, groups, and studies.
Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Receiving Antibiotic Therapy.
Sponsor: University of Thessaly
Summary
This open-label interventional study aims to evaluate the acceptability and adherence of adult participants to the multistrain probiotic Vivomixx® 460 Neo 9 when administered concurrently with antibiotic therapy. Participants are randomized to receive one of two dosing regimens: a low daily dose or a high daily dose. The study will assess the effects of these regimens on the prevention of antibiotic-associated diarrhea (AAD), gastrointestinal symptoms, and patient adherence and acceptability. The results are intended to provide evidence to optimize the clinical use of probiotics alongside antibiotics.
Official title: Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Receiving Antibiotic Therapy: a Randomized, Open-label Clinical Trial.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-12-12
Completion Date
2026-05-30
Last Updated
2026-02-02
Healthy Volunteers
No
Conditions
Interventions
One sachet of the probiotic daily
Twenty participants will receive one sachet of the probiotic daily.
Two sachets of the probiotic daily
Twenty participants will receive two sachets of the probiotic daily.
Locations (1)
School of Physical Education, Sport Science and Dietetics
Trikala, Greece